Jennifer Freeman
Vice President Clinical Operations
Professional Overview
Jennifer Freeman is an experienced pharmaceutical and biotechnology executive with a proven track record in clinical operations, translational medicine, and drug development. As the Vice President of Clinical Operations at vTv Therapeutics LLC, she oversees the execution of complex clinical trials and the management of cross-functional teams to drive the advancement of the company's promising drug candidates.
Experience Summary
Current Role
As the Vice President of Clinical Operations at vTv Therapeutics, Jennifer is responsible for the strategic planning, operational management, and successful delivery of the company's clinical trial programs. She leads a team of clinical professionals and collaborates closely with cross-functional stakeholders to ensure the timely and efficient conduct of clinical studies, the collection of high-quality data, and the adherence to regulatory requirements.
Career Progression
Prior to her current role, Jennifer held several key positions at vTv Therapeutics, including VP of Clinical Science and Translational Medicine and Director of Clinical Development. In these roles, she was instrumental in the design and implementation of early- and late-stage clinical trials, the integration of translational research data, and the advancement of the company's pipeline. Before joining vTv Therapeutics, Jennifer gained valuable experience as a Consultant at Bioemerge Partners and as a Research Manager at Amplistar, Inc.
Academic Background
Jennifer holds a Bachelor's degree from a reputable university, where she specialized in a relevant field of study. Her academic achievements and knowledge have served as a strong foundation for her successful career in the pharmaceutical and biotechnology industry.
Areas of Expertise
- Clinical trial design and execution
- Cross-functional team leadership and collaboration
- Regulatory compliance and interactions
- Translational research and data integration
- Strategic planning and operational management
- Effective communication and stakeholder engagement
Professional Impact
Throughout her career, Jennifer has played a pivotal role in the advancement of several drug candidates, contributing to the successful completion of complex clinical trials and the generation of valuable data to support regulatory submissions. Her expertise and leadership have been instrumental in driving the progress of vTv Therapeutics' pipeline, with a focus on addressing unmet medical needs in various therapeutic areas.
Conclusion
With her extensive experience in clinical operations, translational medicine, and drug development, Jennifer Freeman is a valued asset to the vTv Therapeutics team. Her strategic vision, operational excellence, and collaborative approach have positioned her as a respected leader in the pharmaceutical and biotechnology industry, poised to drive continued innovation and advance the company's efforts to develop transformative therapies for patients.